At the end of Q2 2026, 28 institutions reported holding Sinovac Biotech Ltd. (SVA) in their 13F filings, unchanged from Q1 2026. 2 opened new positions and 2 sold out. The largest holders were Orbimed Advisors LLC ($184.5M), Vivo Capital, LLC ($38.2M) and Neumann Advisory Hong Kong Ltd ($2.0M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
Company
Sinovac Biotech Ltd.
CUSIP
P8696W104
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
Institutions
Total Value
New Positions
2
$0
Exits
2
$0
All 13F filers, Q1 2026 → Q2 2026: 13,314 shares bought and 41,505 shares sold, net −28,191 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.